Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

484

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2013

Conditions
Tularemia
Interventions
BIOLOGICAL

Live F tularensis Vaccine

Subjects will receive one drop of reconstituted F tularensis vaccine (approximately 0.0025 ml), applied with a bifurcated needle to the volar surface of the forearm, and the skin will be pricked 15 times over the prepared area. A booster dose will be given at the same dose volume and route of administration if the titer (days 56-84) is inadequate (\< 1:20).

Trial Locations (1)

21702

U.S. Army Medical Research Institute of Infectious Diseases, Fort Deterick

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT00584844 - Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine | Biotech Hunter | Biotech Hunter